These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 14727853
1. A novel in vitro release technique for peptide containing biodegradable microspheres. Kostanski JW, DeLuca PP. AAPS PharmSciTech; 2000 Mar 09; 1(1):E4. PubMed ID: 14727853 [Abstract] [Full Text] [Related]
2. Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres. Kostanski JW, Thanoo BC, DeLuca PP. Pharm Dev Technol; 2000 Mar 09; 5(4):585-96. PubMed ID: 11109259 [Abstract] [Full Text] [Related]
3. Evaluation of Orntide microspheres in a rat animal model and correlation to in vitro release profiles. Kostanski JW, Dani BA, Reynolds GA, Bowers CY, DeLuca PP. AAPS PharmSciTech; 2000 Oct 01; 1(4):E27. PubMed ID: 14727892 [Abstract] [Full Text] [Related]
4. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist. Du L, Cheng J, Chi Q, Qie J, Liu Y, Mei X. Chem Pharm Bull (Tokyo); 2006 Sep 01; 54(9):1259-65. PubMed ID: 16946531 [Abstract] [Full Text] [Related]
5. Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres. Dani BA, DeLuca PP. AAPS PharmSciTech; 2001 Oct 17; 2(4):22. PubMed ID: 14727859 [Abstract] [Full Text] [Related]
6. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres. Jiang G, Woo BH, Kang F, Singh J, DeLuca PP. J Control Release; 2002 Feb 19; 79(1-3):137-45. PubMed ID: 11853925 [Abstract] [Full Text] [Related]
7. Effect of the concurrent LHRH antagonist administration with a LHRH superagonist in rats. Kostanski JW, Dani BA, Schrier B, DeLuca PP. Pharm Res; 2000 Apr 19; 17(4):445-50. PubMed ID: 10870989 [Abstract] [Full Text] [Related]
8. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres. Wang J, Wang BM, Schwendeman SP. J Control Release; 2002 Aug 21; 82(2-3):289-307. PubMed ID: 12175744 [Abstract] [Full Text] [Related]
9. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions. Murty SB, Goodman J, Thanoo BC, DeLuca PP. AAPS PharmSciTech; 2003 Oct 13; 4(4):E50. PubMed ID: 15198545 [Abstract] [Full Text] [Related]
10. Development of a sustained-release system for perivascular delivery of dipyridamole. Zhu W, Masaki T, Bae YH, Rathi R, Cheung AK, Kern SE. J Biomed Mater Res B Appl Biomater; 2006 Apr 13; 77(1):135-43. PubMed ID: 16206204 [Abstract] [Full Text] [Related]
11. In-vitro/in-vivo studies of the biodegradable poly-(D,L-lactide-co-glycolide) microspheres of a novel luteinizing hormone-releasing hormone antagonist for prostate cancer treatment. Du L, Mei X, Wang C, Li X, Zhang F, Jin Y. Anticancer Drugs; 2011 Mar 13; 22(3):262-72. PubMed ID: 21360849 [Abstract] [Full Text] [Related]
12. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres. Jiang G, Qiu W, DeLuca PP. Pharm Res; 2003 Mar 13; 20(3):452-9. PubMed ID: 12669968 [Abstract] [Full Text] [Related]
13. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition. Kwon YM, Kim SW. Pharm Res; 2004 Feb 13; 21(2):339-43. PubMed ID: 15032317 [Abstract] [Full Text] [Related]
14. Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization. Chen W, Lu DR. J Microencapsul; 1999 Feb 13; 16(5):551-63. PubMed ID: 10499836 [Abstract] [Full Text] [Related]
15. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation. Bittner B, Mäder K, Kroll C, Borchert HH, Kissel T. J Control Release; 1999 May 01; 59(1):23-32. PubMed ID: 10210719 [Abstract] [Full Text] [Related]
16. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres. Wang J, Wang BM, Schwendeman SP. Biomaterials; 2004 May 01; 25(10):1919-27. PubMed ID: 14738856 [Abstract] [Full Text] [Related]
17. Preparation, characterization and in vivo evaluation of 120-day poly(D,L-lactide) leuprolide microspheres. Woo BH, Kostanski JW, Gebrekidan S, Dani BA, Thanoo BC, DeLuca PP. J Control Release; 2001 Aug 10; 75(3):307-15. PubMed ID: 11489318 [Abstract] [Full Text] [Related]
18. Enhancing initial release of peptide from poly(d,l-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load. Ravivarapu HB, Lee H, DeLuca PP. Pharm Dev Technol; 2000 Aug 10; 5(2):287-96. PubMed ID: 10810758 [Abstract] [Full Text] [Related]
19. Importance of the test medium for the release kinetics of a somatostatin analogue from poly(D,L-lactide-co-glycolide) microspheres. Blanco-Príeto MJ, Besseghir K, Orsolini P, Heimgartner F, Deuschel C, Merkle HP, Nam-Trân H, Gander B. Int J Pharm; 1999 Jul 20; 184(2):243-50. PubMed ID: 10387954 [Abstract] [Full Text] [Related]
20. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. Uchida T, Yagi A, Oda Y, Nakada Y, Goto S. Chem Pharm Bull (Tokyo); 1996 Jan 20; 44(1):235-6. PubMed ID: 8582042 [Abstract] [Full Text] [Related] Page: [Next] [New Search]